I worry that addiction to stock buybacks is a terminal disease for companies like IBM. Imagine what $65B invested in R&D over the last eight years could have yielded in the future instead of being poured down a financial sewer.
Most companies have a limit to the amount of R&D they can do before running into a wall where the payback becomes unprofitable (for complicated reasons).